VA Connecticut Healthcare System, West Haven, CT, United States.
Mount Sinai School of Medicine, Icahn School of Medicine at Mount Sinai, United States.
J Psychiatr Res. 2022 Aug;152:219-224. doi: 10.1016/j.jpsychires.2022.05.034. Epub 2022 Jun 9.
Frontline healthcare workers (FHCWs) responding to the COVID-19 pandemic develop posttraumatic stress disorder (PTSD), major depressive disorder (MDD) and generalized anxiety disorder (GAD) symptoms. Such symptoms are associated with burnout, occupational and relational difficulties. In the current study, we examined the prospective association between acute transdiagnostic COVID-19-related PTSD, MDD, and GAD symptoms at pandemic outset, and burnout and functional difficulties several months later in FHCWs in New York City.
Wave 1 symptoms of COVID-19-related PTSD, MDD, and GAD, were assessed in 787 FHCWs from April 14 to May 11th, 2020. Burnout and occupational difficulties were assessed at wave 1 and wave 2, approximately 7 months later.
After adjusting for wave 1 burnout, wave 1 MDD symptoms, particularly sleep difficulties, loss of interest, and feeling tired/having little energy, collectively explained 42% incremental variance in this outcome. After adjusting for wave 1 work difficulties, MDD and PTSD symptoms, particularly feeling tired/having little energy, loss of interest, and negative expectations of self/world, collectively explained 42% incremental variance in this outcome. After adjusting for wave 1 relationship difficulties, MDD, GAD, and PTSD symptoms, particularly depressed mood, irritability, and appetite disturbance, explained 26% incremental variance in this outcome.
Results highlight psychiatric symptoms assessed during the acute phase of the COVID-19 pandemic that may help predict burnout and work and relationship difficulties in FHCWs. Early interventions aimed at ameliorating transdiagnostic symptoms of MDD, PTSD, and GAD may help mitigate risk for burnout and functional difficulties in this population.
应对 COVID-19 大流行的一线医护人员(FHCWs)会出现创伤后应激障碍(PTSD)、重度抑郁障碍(MDD)和广泛性焦虑障碍(GAD)症状。这些症状与职业倦怠、职业和人际关系困难有关。在目前的研究中,我们调查了 COVID-19 相关 PTSD、MDD 和 GAD 症状在大流行初期的急性跨诊断与 FHCWs 几个月后倦怠和功能障碍之间的前瞻性关联。
2020 年 4 月 14 日至 5 月 11 日,对来自纽约市的 787 名 FHCWs 进行了 COVID-19 相关 PTSD、MDD 和 GAD 的第 1 波症状评估。大约 7 个月后,在第 1 波和第 2 波评估了倦怠和职业困难。
调整第 1 波倦怠后,第 1 波 MDD 症状,尤其是睡眠困难、兴趣丧失和感到疲倦/精力不足,共同解释了这一结果的 42%增量方差。调整第 1 波工作困难后,MDD 和 PTSD 症状,尤其是疲倦/精力不足、兴趣丧失和对自我/世界的消极期望,共同解释了这一结果的 42%增量方差。调整第 1 波人际关系困难后,MDD、GAD 和 PTSD 症状,尤其是情绪低落、易怒和食欲紊乱,共同解释了这一结果的 26%增量方差。
结果突出了 COVID-19 大流行急性期评估的精神症状,这些症状可能有助于预测 FHCWs 的倦怠和工作及人际关系困难。针对 MDD、PTSD 和 GAD 跨诊断症状的早期干预措施可能有助于减轻该人群的职业倦怠和功能障碍风险。